These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10458280)

  • 21. In vivo evaluation of interactions between biphasic calcium phosphate (BCP)-niobium pentoxide (Nb
    Kiyochi Junior HJ; Candido AG; Bonadio TGM; da Cruz JA; Baesso ML; Weinand WR; Hernandes L
    J Mater Sci Mater Med; 2020 Jul; 31(8):71. PubMed ID: 32712717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of a cellulosic ether carrier on the structure of biphasic calcium phosphate ceramic particles in an injectable composite material.
    Dupraz A; Nguyen TP; Richard M; Daculsi G; Passuti N
    Biomaterials; 1999 Apr; 20(7):663-73. PubMed ID: 10208409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo biological performance of composites combining micro-macroporous biphasic calcium phosphate granules and fibrin sealant.
    Jegoux F; Goyenvalle E; Bagot D'arc M; Aguado E; Daculsi G
    Arch Orthop Trauma Surg; 2005 Apr; 125(3):153-9. PubMed ID: 15761734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-temperature particulate calcium phosphates for bone regeneration.
    Araújo MV; Mendes VC; Chattopadhyay P; Davies JE
    Clin Oral Implants Res; 2010 Jun; 21(6):632-41. PubMed ID: 20666790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of β-tricalcium phosphate granule size and morphology on tissue reaction in vivo.
    Ghanaati S; Barbeck M; Orth C; Willershausen I; Thimm BW; Hoffmann C; Rasic A; Sader RA; Unger RE; Peters F; Kirkpatrick CJ
    Acta Biomater; 2010 Dec; 6(12):4476-87. PubMed ID: 20624495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of sterilization on injectable bone biomaterials.
    Zahraoui C; Sharrock P
    Bone; 1999 Aug; 25(2 Suppl):63S-65S. PubMed ID: 10458278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of adding resorbable chitosan microspheres to calcium phosphate cements for bone regeneration.
    Meng D; Dong L; Wen Y; Xie Q
    Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():266-72. PubMed ID: 25492197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A biodegradable porous composite scaffold of PGA/beta-TCP for bone tissue engineering.
    Cao H; Kuboyama N
    Bone; 2010 Feb; 46(2):386-95. PubMed ID: 19800045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteogenicity of biphasic calcium phosphate ceramics and bone autograft in a goat model.
    Fellah BH; Gauthier O; Weiss P; Chappard D; Layrolle P
    Biomaterials; 2008 Mar; 29(9):1177-88. PubMed ID: 18093645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term evaluation of the degradation behavior of three apatite-forming calcium phosphate cements.
    An J; Liao H; Kucko NW; Herber RP; Wolke JG; van den Beucken JJ; Jansen JA; Leeuwenburgh SC
    J Biomed Mater Res A; 2016 May; 104(5):1072-81. PubMed ID: 26743230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute.
    Daculsi G
    Biomaterials; 1998 Aug; 19(16):1473-8. PubMed ID: 9794521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An injectable bone substitute composed of beta-tricalcium phosphate granules, methylcellulose and hyaluronic acid inhibits connective tissue influx into its implantation bed in vivo.
    Ghanaati S; Barbeck M; Hilbig U; Hoffmann C; Unger RE; Sader RA; Peters F; Kirkpatrick CJ
    Acta Biomater; 2011 Nov; 7(11):4018-28. PubMed ID: 21784183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The biodegradation mechanism of calcium phosphate biomaterials in bone.
    Lu J; Descamps M; Dejou J; Koubi G; Hardouin P; Lemaitre J; Proust JP
    J Biomed Mater Res; 2002; 63(4):408-12. PubMed ID: 12115748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear magnetic resonance spectroscopy of bone substitutes.
    Legrand AP; Sfihi H; Bouler JM
    Bone; 1999 Aug; 25(2 Suppl):103S-105S. PubMed ID: 10458287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties of calcium phosphate ceramics in relation to their in vivo behavior.
    Blokhuis TJ; Termaat MF; den Boer FC; Patka P; Bakker FC; Haarman HJ
    J Trauma; 2000 Jan; 48(1):179-86. PubMed ID: 10647592
    [No Abstract]   [Full Text] [Related]  

  • 36. Bioactivity and osseointegration study of calcium phosphate ceramic of different chemical composition.
    Manjubala I; Sivakumar M; Sureshkumar RV; Sastry TP
    J Biomed Mater Res; 2002; 63(2):200-8. PubMed ID: 11870654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study on bone regeneration by synthetic octacalcium phosphate with various granule sizes.
    Murakami Y; Honda Y; Anada T; Shimauchi H; Suzuki O
    Acta Biomater; 2010 Apr; 6(4):1542-8. PubMed ID: 19837192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of calcium phosphate microstructure on bone-related cells in vitro.
    Li X; van Blitterswijk CA; Feng Q; Cui F; Watari F
    Biomaterials; 2008 Aug; 29(23):3306-16. PubMed ID: 18485476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study.
    Taylor JC; Cuff SE; Leger JP; Morra A; Anderson GI
    Int J Oral Maxillofac Implants; 2002; 17(3):321-30. PubMed ID: 12074446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of microporosity on osteoinduction of calcium phosphate bone graft substitute biomaterials.
    Chan O; Coathup MJ; Nesbitt A; Ho CY; Hing KA; Buckland T; Campion C; Blunn GW
    Acta Biomater; 2012 Jul; 8(7):2788-94. PubMed ID: 22475784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.